APN401
invIOs
['solid tumor']
invios releases positive clinical data for apn-401 in solid tumors at aacr annual meeting 2023. more info: #apn401 $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT